TOPCU, T. Et Al. 2018. The clinical importance of serum urokinase plasminogen activator receptor and carbonic anhydrase IX levels and the effect of anthracycline-based adjuvant chemotherapy on these biomarkers in breast cancer.. Journal of cancer research and therapeutics , vol.14 , 608-613.

TOPCU, T., Ozdemir, F., Kavgaci, H., GUNALDI, M., KOCOGLU, H., IMAMOGLU, G., ... Mentese, A.(2018). The clinical importance of serum urokinase plasminogen activator receptor and carbonic anhydrase IX levels and the effect of anthracycline-based adjuvant chemotherapy on these biomarkers in breast cancer.. Journal of cancer research and therapeutics , vol.14, 608-613.

TOPCU, SERAP Et Al. "The clinical importance of serum urokinase plasminogen activator receptor and carbonic anhydrase IX levels and the effect of anthracycline-based adjuvant chemotherapy on these biomarkers in breast cancer.," Journal of cancer research and therapeutics , vol.14, 608-613, 2018

TOPCU, SERAP Ö. Et Al. "The clinical importance of serum urokinase plasminogen activator receptor and carbonic anhydrase IX levels and the effect of anthracycline-based adjuvant chemotherapy on these biomarkers in breast cancer.." Journal of cancer research and therapeutics , vol.14, pp.608-613, 2018

TOPCU, T. Et Al. (2018) . "The clinical importance of serum urokinase plasminogen activator receptor and carbonic anhydrase IX levels and the effect of anthracycline-based adjuvant chemotherapy on these biomarkers in breast cancer.." Journal of cancer research and therapeutics , vol.14, pp.608-613.

@article{article, author={SERAP ÖZER YAMAN Et Al. }, title={The clinical importance of serum urokinase plasminogen activator receptor and carbonic anhydrase IX levels and the effect of anthracycline-based adjuvant chemotherapy on these biomarkers in breast cancer.}, journal={Journal of cancer research and therapeutics}, year=2018, pages={608-613} }